MRSN Mersana therapeutics Mersana just had to stop their clinical trials on their cancer drug because someone in their trials died, yet they didn't collapse in price... $500Mil market cap on a clinical stage company. I mean I don't blame the market for not liking this mute, arrogant French Canadian dumpster fire but come on at least we didn't kill anyone.